Know how omnichannel communications can transform your KOL relationships
Effectively engaging with KOLs is critical to pharma’s business and digital communications has become central to building these relationships. But the rapid growth in the number of digital channels has saturated the market leading to KOL digital fatigue. How can you punch through the noise to really get your messages to KOLs? What are KOLs expectations? Which channels are effective? How can you measure channel performance? What does a good omnichannel strategy look like? Turn to this report for expert insights into the latest developments.
Table of Contents
- Subject synopsis
- Research methodology and objectives
- Key insights summary
- Issues and insights
- Factors aiding channel selection
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Selecting complementary channels
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- KPIs for measuring the individual and combined impact of channels
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Resources for selecting the right channels
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Emerging opportunities and challenges
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Factors aiding channel selection
Companies Mentioned
- AstraZeneca
- Doximity
- Gilead Sciences
- GlaxoSmithKline
- Myspace
- Novartis
- Sanofi
- Sermo
- Zoom
